RecruitingNCT04765150

Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification

Sponsor

Jonsson Comprehensive Cancer Center

Enrollment

275 participants

Start Date

Apr 1, 2021

Study Type

OBSERVATIONAL

Conditions

Prostate Carcinoma

Summary

This study evaluates how new magnetic resonance imaging (MRI) and artificial intelligence techniques improve the image quality and quantitative information for future prostate MRI exams in patients with suspicious of confirmed prostate cancer. The MRI and artificial intelligence techniques developed in this study may improve the accuracy in diagnosing prostate cancer in the future using less invasive techniques than what is currently used.

Eligibility

Sex: MALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is using advanced MRI technology combined with artificial intelligence to improve how prostate cancer is detected and classified, aiming to reduce unnecessary biopsies and improve accuracy of diagnosis. **You may be eligible if...** - You are a male 18 years or older - You have a clinical suspicion of prostate cancer or a biopsy-confirmed prostate cancer - You have had or are scheduled to have a high-resolution (3T multi-parametric) prostate MRI at UCLA - You are able to give consent **You may NOT be eligible if...** - You have contraindications to MRI (such as a pacemaker, certain metal implants, or severe claustrophobia) - You have contraindications to the MRI contrast dye (gadolinium) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.